Home・Listă Acțiuni・Alkermes PLC

Alkermes PLC

Deschisă

SectorSănătate

49.33 -1.54

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

49.05

Maxim

50.66

Indicatori cheie
By Trading Economics
Venit	-116M -66M
Vânzări	8.4M 393M
P/E Medie Sector	58.589 64.641
EPS	0.38
Marjă de profit	-16.92
Angajați	2,050
EBITDA	-98M -22M

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+16.01% upside

Dividende
By Acuity
Următoarele câștiguri	27 oct. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	3.1B 8.8B
Deschiderea anterioară	50.87
Închiderea anterioară	49.33

Sentimentul știrilor

By Acuity

10%

90%

5 / 340 Clasament în Healthcare

Alkermes PLC Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

3 aug. 2026, 20:02 UTC

Alkermes shares are higher today, driven by significant gains in the overall market and major technology stocks, despite earlier session pullbacks.

31 iul. 2026, 19:36 UTC

Alkermes Plc shares are lower today, impacted by declines in the Biotechnology sub-sector. The stock remains below its 20-day moving average.

30 iul. 2026, 19:58 UTC

Alkermes Plc shares are higher during Thursday's session, reflecting a broader recovery in tech shares despite remaining below the 20-day moving average.

29 iul. 2026, 20:03 UTC

News

Macro Event

Shares declining despite price target increases from JP Morgan, Baird.

28 iul. 2026, 20:02 UTC

News

Event

Alkermes Plc shares are lower after reporting second-quarter earnings of 0 cents per share, below the consensus estimate of 29 cents.

24 iul. 2026, 19:46 UTC

Alkermes Plc shares are lower today, pulling back after an early high. No specific news has been identified to explain the decline.

22 iul. 2026, 19:36 UTC

Alkermes Plc shares are lower today, despite an earlier session high, amid rising crude oil prices and concerns over potential supply disruptions.

21 iul. 2026, 18:46 UTC

Alkermes shares are higher today, supported by improved market sentiment and renewed interest in AI stocks. The asset is trading near its one-month range high.

20 iul. 2026, 22:01 UTC

Alkermes Plc shares declined after-market, retracing from earlier peaks. The asset is currently below its 20-day moving average.

Comparație

Modificare preț

Alkermes PLC Așteptări

Obiectiv de preț

By TipRanks

16.01% sus

Prognoză pe 12 luni

Medie 57.46 USD 16.01%

Maxim 65 USD

Minim 38 USD

În baza a 13 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruAlkermes PLC - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

13 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 13 analiști care au acordat evaluări ale acțiunilor Alkermes PLC - Dist în ultimele 3 luni.

Sentiment

By Acuity

5 / 340 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Alkermes PLC

Alkermes plc is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of marketed drug products and a clinical pipeline of products that address central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis (MS). The Company's products include ARISTADA, VIVITROL, INVEGA SUSTENNA, XEPLION, INVEGA TRINZA, TREVICTA, RISPERDAL CONSTA, AMPYRA, FAMPYRA, BYDUREON, Aripiprazole lauroxil, ALKS 5461, ALKS 3831, ALKS 8700, ALKS 6428, ALKS 4230 and ALKS 7119. The Company's product platforms include injectable extended-release microsphere technology, LinkeRx technology, NanoCrystal technology and oral controlled release (OCR) technology. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia.